Genobank.io
- Company typePrivate
- Founded2020
- HeadquartersPalo Alto, United States
- Headcount1–10
- GTM typeB2B and B2C
- OfferingSoftware
Genobank.io firmographics
Firmographics- Name
- Genobank.io
- Legal name
- GenoBank.io Inc.
- Website
- https://genobank.io
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Genobank.io industry classification
Industry- Product category
- Blockchain Genomics Platform
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Medical Laboratories (8071), Patent Owners & Lessors (6794), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD)
- akta.pro secondary industries
- Genetic Counseling & Prenatal Testing Telehealth (carrier screening, NIPT counseling) (HLALAHAK), Molecular Diagnostics & Genomics Laboratories (HLAFAMAE), Genomics & Molecular Diagnostics (Trial Support) (HLAGAEAD), Sample / Biorepository & Biobank Informatics (Chain-of-Custody) (HLAGAJAH), Biobank & Biospecimen Management LIMS (HLACAMAG)
Keywords
Where Genobank.io is headquartered
LocationHeadquarters
- HQ city
- Palo Alto
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Genobank.io business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
Revenue model
- GenoClaw DNA Kit Sales: One-time sale of the GenoClaw Kit at $499 per unit (pre-sale), including 30x whole-exome sequencing at a CLIA-certified US lab, raw FASTQ/BAM/VCF file delivery, numbered BioNFT on Sequentia, GenoClaw AI agent on encrypted USB, MyChart integration, lifetime BioVault access, and free US shipping. No subscription required for core kit functionality.
- Cloud BioVault Subscription: Optional $9/month Cloud BioVault subscription providing encrypted sandbox for mobile/tablet access to genome, monthly variant re-analysis as new research drops, physician-ready PDF export, and family sharing for up to 4 BioNFTs. Billed only after kit ships; cancelable anytime.
- Story Protocol Genomic IP Licensing: Patients can optionally license their BioNFT genomic data via Story Protocol's Programmable IP License (BioPIL) to researchers. Revenue from license fees is automatically distributed to data owners, analysis service providers, and the Story Protocol treasury per license terms. Opt-in only; default state is 'off the market'.
- x402 BioData Router Micropayments: Coinbase x402 HTTP-native payment protocol enables agent-to-agent micropayments for genomic data access and analysis across the decentralized biobank network. Data commerce flows through the BioData Router smart contract with Byzantine-fault-tolerant quality assurance.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | GenoClaw Kit Edition 01 — one-time purchase DNA kit with AI agent |
| Subscription | Monthly | Cloud BioVault — optional encrypted cloud access add-on |
Go-to-market motion4 records
Distribution channels5 records
Marketing channels8 records
Genobank.io product offering
Product offeringCore offering
GenoBank.io operates a patient-owned genomic data platform that converts physical DNA samples into patented BioNFTs (US Patents 11,984,203 B1 and 11,915,808 B1) on its Sequentia Layer-1 blockchain, enabling patients to control, license, and revoke access to their genetic data. The company sells a direct-to-consumer GenoClaw DNA Kit ($499 pre-sale) that includes 30x whole-exome sequencing, a local AI agent, and Tangem NFC wallet, plus a $9/month Cloud BioVault subscription. It also offers laboratory certificates, partner lab onboarding (52 organizations across 8+ countries), and Story Protocol-based BioIP licensing to researchers.
Product overview
GenoBank.io is a patient-owned genomic data platform built on blockchain technology, offering a modular ecosystem of products centered on the BioNFT (US Patents 11,984,203 B1 and 11,915,808 B1) — a tokenized biosample system that gives patients verifiable blockchain ownership of their genomic data. The core platform (GenoBank.io) powers 7,000+ GenoVaults with 150+ research partnerships and $6.9M+ tokenized BioIP value. The product portfolio includes: GenoVault personal data dashboard, OpenCRAVAT variant annotation (220+ sources), SOMOS DAO ancestry analysis, AlphaGenome AI pathogenicity scoring, and the GenoClaw Kit (Edition 01 pre-sale, $499, shipping May 2026) featuring 30x whole-exome sequencing, a local GenoClaw AI agent, and Tangem NFC card for wallet-free BioNFT minting. The Sequentia blockchain (Chain ID: 15132025) serves as the underlying infrastructure, while Story Protocol enables BioPIL programmable IP licensing. All genomic services connect via Epic FHIR R4 for clinical records, and Anthropic Claude provides AI-powered genomic interpretation.
Differentiator
Problem solved
Functional benefit
Brands
- GenoVault: Patient-owned health and genomic data vault with blockchain-verified consent management
- GenoClaw
- SOMOS DAO
- BioNFT
- BioIP
- Sequentia Network
- BioFS Protocol
- BioRouter
- BioVault
- OpenCRAVAT
- AlphaGenome
- Clara AI
Products and services
- GenoClaw Kit World's first AI-friendly DTC DNA kit combining 30x whole-exome sequencing at a CLIA-certified US lab, raw FASTQ/BAM/VCF file delivery, a numbered BioNFT on Sequentia, GenoClaw local AI agent on encrypted USB drive, MyChart integration via Epic FHIR R4, lifetime BioVault access, free US shipping, and a Tangem NFC card for wallet-free BioNFT minting. For health-conscious individuals and rare-disease patients seeking AI-friendly personal genomics with full data ownership.
- Cloud BioVault Optional $9/month encrypted cloud sandbox subscription for GenoClaw Kit customers, enabling mobile/tablet/laptop genome querying, monthly variant re-analysis as new research emerges, physician-ready PDF export, and family sharing for up to 4 BioNFTs. Billed only after the kit ships and cancelable anytime.
- GenoBank.io Platform (GenoVault Dashboard) Patient-owned genomic data platform with the GenoVault personal dashboard where individuals store, manage, and control access to VCF/BAM/FASTQ genomic files, FHIR clinical records, and biosample metadata via blockchain-verified consent and BioNFT technology. Supports 7,000+ GenoVaults, 150+ research partnerships, and $6.9M+ tokenized BioIP value across the platform.
- Laboratory Certificates Blockchain-certified laboratory test results with QR code verification, accepted by the US Department of Homeland Security for travel. Enables laboratories to create verifiable certificates with immutable on-chain records and QR-code-based authenticity verification for COVID-19 and other diagnostic test results.
- BioIP Licensing on Story Protocol (BioPIL) Optional genomic IP licensing service built on Story Protocol blockchain (Chain ID 1500) that enables patients to wrap their BioNFTs as programmable IP Assets with revocable BioPIL license terms, and researchers to acquire licenses programmatically with automatic revenue distribution to data owners, analysis providers, and the Story Protocol treasury. Default state is opt-out ('off the market').
- Sequentia Network Specialized Layer-1 blockchain (Chain ID 15132025) built on Ethereum Clique Proof-of-Authority consensus, purpose-built for genomic data federation, bioinformatics computation, and programmable IP licensing. Features deterministic 15-second block times, EVM compatibility, BioData Router smart contract, LabNFT identity tokens, BioNFT biosample tokens, and a partner chain ecosystem. Master node operated at 52.90.163.112.
Quantifiable outcome
- 7,000+ patients have created GenoVaults and control their genomic data on-chain with full sovereignty
- +3 more outcomes
Companies that use Genobank.io
Customer profileNamed customers11 records
Segments3 records
Ideal customer profiles3 records
Genobank.io technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration21 records
AI capability10 records
Feature11 records
Genobank.io partnerships and signals
Strategic signalPartnerships
16 partnerships are on record, tiered core, secondary and minor.
- Story ProtocolcoreStory Protocol (Chain ID: 1500) is the blockchain infrastructure for genomic intellectual property management on GenoBank.io. Every genomic file registered on Sequentia can be registered as a Story Protocol IP Asset with programmable BioPIL license terms. Revenue from license fees is automatically distributed to data owners via Story's licensing smart contracts. This is the core monetization layer for patient-owned genomic IP.
- Avalanche NetworkcoreAvalanche C-Chain (Chain ID: 43114) handles primary blockchain operations for smart contract execution, providing fast, secure transactions with Avalanche C-Chain redundancy alongside Sequentia Network. Used for BioNFT minting, consent transactions, and smart contract governance.
- IPFS NetworkcoreThe InterPlanetary File System provides decentralized, distributed genomic file storage for GenoBank.io. Files are content-addressed by cryptographic hash, ensuring data integrity. All genomic data is encrypted before storage on IPFS. Access is controlled through the GenoBank IPFS gateway (ipfs.genobank.app) requiring blockchain authentication.
- Epic (FHIR R4 / SMART-on-FHIR)coreGenoBank.io is a registered Epic third-party app enabling SMART-on-FHIR OAuth2 connectivity across 65,000+ US hospitals. Patients authorize read-only access to their hospital's MyChart; GenoBank never receives portal credentials. Supports import of Patient, Condition, MedicationRequest, Observation, AllergyIntolerance, Immunization, Procedure, DiagnosticReport, DocumentReference, Encounter FHIR R4 resources.
- OpenCRAVATcoreOpenCRAVAT is a decentralized genomic variant annotation network integrated as a Sequentia Network partner chain. Instead of centralized servers, annotation jobs are distributed across nodes. Features 220+ annotation sources (ClinVar, gnomAD, COSMIC), modular annotator system, SQLite output, and expert curator AI integration. Integration with GenoBank BioFS Protocol for consent-gated variant annotation.
- AlphaGenome (DeepMind AlphaMissense)coreAlphaGenome leverages DeepMind's AlphaMissense model for variant pathogenicity prediction via API. Results are tokenized and linked to parent VCF as derivative IP assets on Sequentia/Story Protocol. Provides pathogenicity scores (0-1) for genomic variants, enabling clinical interpretation of variants of uncertain significance.
- Anthropic Claude AIcoreClaude AI (Anthropic) provides AI-powered genomic analysis integrated into GenoBank.io. Powers the GenoClaw AI agent (local-first), the GenoBank web app AI assistant for families and researchers, and multi-agent adversarial co-interpretation workflows. All AI interactions are logged on-chain for auditability. No data retention by Anthropic.
- SOMOS DAOcoreSOMOS DAO provides ancestry composition analysis as a Sequentia partner chain. Accepts 23andMe, Ancestry.com, and VCF file inputs. Processing runs via ECS Fargate container (10-15 minutes), outputting a 24-population ancestry breakdown plus haplogroups. Results are tokenized as an ancestry NFT with Story Protocol licensing.
- AlphaFoldsecondaryAlphaFold integration enables variant-to-protein structure prediction as a Sequentia partner chain service. Pipeline: Variant → Protein sequence change → AlphaFold 3D structure prediction → Structural impact analysis. Enables assessment of whether genetic variants cause structural protein disruption.
- Worldcoin / World IDsecondaryWorld ID integration enables proof-of-personhood verification to be added to GenoBank.io's BioWallet — the world's first decentralized laboratory ID. Enables users to prove they are human (without revealing identity) when registering biosamples, licensing genomic data, or recovering lost credentials via DNA.
- TangemsecondaryTangem NFC card included with GenoClaw Kit. Users tap the Tangem Card to their phone to mint their BioNFT via NFC — no crypto wallet setup required. The Tangem Card handles the wallet infrastructure, making Web3 genomics accessible to non-crypto-native consumers.
- Magic (Google OAuth Bridge)secondaryMagic provides OAuth-to-Web3 authentication bridge enabling users to sign in with their Google account, which Magic converts to a Web3 wallet. Supports MetaMask, GenoBank BioWallet, and Magic for wallet-based authentication. Reduces friction for non-crypto-native users onboarding to the platform.
- Coinbase (x402 Protocol)secondaryCoinbase's x402 HTTP-native payment protocol enables agent-to-agent micropayments for genomic data access and analysis across the decentralized biobank network. The x402 BioData Router provides Byzantine-fault-tolerant quality assurance for automated data commerce between AI agents and data providers.
- NiMEDix (Nigeria)minorNiMEDix is a Nigerian blockchain/AI company focused on bridging gaps in remittances, healthcare funding collaboration, and healthcare access services. Announced June 2021 as a strategic partnership for healthcare blockchain expansion in Africa.
- Bustamante Lab (Florida)minorBustamante Lab is a research and development laboratory in Hialeah, Florida. Announced as a GenoBank.io partnership in June 2021 for blockchain-enabled laboratory services and COVID-19 testing verification.
- Government of Quintana Roo (Mexico)minorGenoBank.io partnered with the Government of the State of Quintana Roo, Mexico to verify authenticity of COVID-19 test results using the Avalanche blockchain platform. Combatting test fraud was the primary use case for this government partnership.
Scale indicators12 records
Recent moves6 records
Expansion highlights7 records
Genobank.io competitors and assessment
Company assessmentBroad incumbents
- AncestryDNA: World's largest consumer DNA network with 20M+ users, focused on genealogy and increasingly health. Listed by GenoBank.io as a recognized DTC data source; competes for the same consumer genomic-data mindshare that GenoBank.io targets.
- 23andMe: Pioneer in direct-to-consumer genetic testing with a massive consented database. GenoBank.io itself lists 23andMe as a recognized data source in its GenoBank catalog, positioning it as both a competitor (DTC genomics) and an integration partner for legacy data portability.
- Invitae: Leading medical genetics company offering clinical-grade genetic testing across multiple specialties. Listed in GenoBank.io's DTC ecosystem and shares the same CLIA-certified lab ecosystem that GenoBank.io's LabNFT infrastructure verifies on-chain.
Direct peers
- Dante Labs: Whole-genome sequencing provider selling DTC WGS kits internationally. Listed in GenoBank.io's recognized data catalog; competes for the same price-conscious WGS consumer that GenoClaw targets with 30x WES at $499.
- Nebula Genomics: Whole-genome sequencing DTC company co-founded by George Church that emphasizes privacy-preserving, blockchain-based access to genomic data. Closest direct comparator to GenoBank.io given its explicit use of blockchain for genomic data control and similar WGS + AI-agent positioning.
- Veritas Genetics: Whole-genome sequencing provider with explicit positioning around consumer ownership of genetic data. Listed as a recognized GenoBank.io data source; competes in the premium WGS tier that GenoClaw Kit Edition 01 also targets.
Emerging players
- FamilyTreeDNA: Genetic genealogy and ancestry testing company. Listed in GenoBank.io's recognized data catalog; competes for the same ancestry-curious consumer that SOMOS DAO serves.
- Color Genomics: Clinical-grade genetic testing company offering hereditary cancer, cardiovascular, and pharmacogenomics panels. Competes for the same health-conscious consumer segment that GenoClaw Kit positions for cancer-risk and PGx skills.
- Helix DNA: DTC genomics platform with an app-driven DNA marketplace model. Listed in GenoBank.io's recognized catalog and shares the marketplace-style approach to genomic data applications.
Regional players
- MyHeritage DNA: Genetic testing service with strong European user base and family-tree integrations. Comparable to GenoBank.io's international lab network ambition and a likely data-import target for GenoVault users outside the US Edition 01 footprint.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat7 records
Key risks7 records
Key highlights7 records
Customer concentration
Genobank.io social profiles
Digital presenceGenobank.io compliance and trust
Trust signalCompliance14 records
Genobank.io financial estimates
Financial estimateRevenue estimate
Valuation estimate
Genobank.io leadership team
Management profileNumber of profiles
Profiles1 record
Genobank.io funding detail
Funding detailFunding overview
Funding rounds4 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Genobank.io M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Genobank.io
What does Genobank.io do?
GenoBank.io operates a patient-owned genomic data platform that converts physical DNA samples into patented BioNFTs (US Patents 11,984,203 B1 and 11,915,808 B1) on its Sequentia Layer-1 blockchain, enabling patients to control, license, and revoke access to their genetic data. The company sells a direct-to-consumer GenoClaw DNA Kit ($499 pre-sale) that includes 30x whole-exome sequencing, a local AI agent, and Tangem NFC wallet, plus a $9/month Cloud BioVault subscription. It also offers laboratory certificates, partner lab onboarding (52 organizations across 8+ countries), and Story Protocol-based BioIP licensing to researchers.
Is Genobank.io a public or private company?
Genobank.io is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Genobank.io founded?
Genobank.io was founded in 2020. It employs 1 to 10 people.
Where is Genobank.io based?
Genobank.io is headquartered in Palo Alto, United States, in the North America region.
How does Genobank.io make money?
Four revenue lines are on record. GenoClaw DNA Kit Sales are the primary driver. The others are cloud BioVault Subscription, story Protocol Genomic IP Licensing and x402 BioData Router Micropayments.
Who are Genobank.io's main competitors?
Broad incumbents on record are AncestryDNA, 23andMe and Invitae. Direct peers are Dante Labs, Nebula Genomics and Veritas Genetics. Emerging players are FamilyTreeDNA, Color Genomics and Helix DNA. MyHeritage DNA is listed as a regional player.
Does Genobank.io have an API?
Yes. Genobank.io exposes a public API. Developer documentation is at genobank.app/docs.
What industry is Genobank.io in?
Genobank.io's product category is Blockchain Genomics Platform. Its primary akta.pro industry code is HLAAALAD, Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics), with a secondary code of HLALAHAK, Genetic Counseling & Prenatal Testing Telehealth (carrier screening, NIPT counseling). Its NAICS code is 621511 and its SIC code is 8071.